Studies
D740FC00001, Surovatamig, AbKD:
Internal Medicine
Nephrology
Kidney Disease
Adult Subjects
The purpose of this study is to assess the safety, tolerability, pharmacokinetic, and efficacy of surovatamig administered by subcutaneous injection in adult participants with primary membranous nephropathy.